Posttranscriptional regulation of the telomerase hTERT by gambogic acid in human gastric carcinoma 823 cells

Cancer Letters

Volumn 262, Issue 2, 2008, Pages 223-231

  Zhao, Qing ^a   Yang, Yong ^a   Yu, Jun ^a   You, Qi Dong ^a   Zeng, Shi ^a   Gu, Hong Yan ^a   Lu, Na ^a   Qi, Qi ^a   Liu, Wei ^a   Wang, Xiao Tang ^b   Guo, Qing Long ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Akt; c Myc; Gambogic acid; Gastric carcinoma; Telomerase hTERT

Indexed keywords

CELECOXIB; GAMBOGIC ACID; MYC PROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; GENES, MYC; HUMANS; ONCOGENE PROTEIN V-AKT; PYRAZOLES; RNA PROCESSING, POST-TRANSCRIPTIONAL; STOMACH NEOPLASMS; SULFONAMIDES; TELOMERASE; TRANSFECTION; XANTHONES;

EID: 40649108043     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.002     Document Type: Article

References (30)

1. Liesenklas W., and Auterhoff H. The constitution of gambogic acid and its isomerization. 4. Chemistry of gum-resin. Arch. Pharm. Ber. Dtsch. Pharm. Ges. 299 (1966) 797-798
2. Lu G.B., Yang X.X., and Huang Q.S. Isolation and structure of neo-gambogic acid from Gamboge (Garcinia hanburryi). Yao Xue Xue Bao 19 (1984) 636-639
3. Zhao L., Guo Q.L., You Q.D., Wu Z.Q., and Gu H.Y. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol. Pharm. Bull. 27 (2004) 998-1003
4. Wu Z.Q., Guo Q.L., You Q.D., Zhao L., and Gu H.Y. Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol. Pharm. Bull. 27 (2004) 1769-1774
5. Kasibhatla S., Jessen K.A., Maliartchouk S., Wang J.Y., English N.M., Drewe J., Qiu L., Archer S.P., Ponce A.E., Sirisoma N., Jiang S., Zhang H.Z., Gehlsen K.R., Cai S.X., Green D.R., and Tseng B. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc. Natl. Acad. Sci. USA 102 (2005) 12095-12100
6. Yu J., Guo Q.L., You Q.D., Zhao L., Gu H.Y., Yang Y., Zhang H.W., Tan Z., and Wang X. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis 28 (2007) 632-638
7. Yang Y., Yang L., You Q.D., Nie F.F., Gu H.Y., Zhao L., Wang X.T., and Guo Q.L. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett. 256 (2007) 259-266
8. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
9. Liu W.J., Jiang J.F., Xiao D., and Ding J. Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem. Pharmacol. 64 (2002) 1677-1687
10. Liu K., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., and Weng N.P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. USA 96 (1999) 5147-5152
11. Weinrich S.L., Pruzan R., Ma L., Ouellette M., Tesmer V.M., Holt S.E., Bodnar A.G., Lichtsteiner S., Kim N.W., Trager J.B., Taylor R.D., Carlos R., Andrews W.H., Wright W.E., Shay J.W., Harley C.B., and Morin G.B. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17 (1997) 498-502
12. Wu A., Ichihashi M., and Ueda M. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors. Cancer 86 (1999) 2038-2044
13. Renaud S., Bosman F.T., and Benhattar J. Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter. Biochem. Biophys. Res. Commun. 300 (2003) 47-54
14. Liu K., Hodes R.J., and Weng N. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J. Immunol. 166 (2001) 4826-4830
15. Yu J., Guo Q.L., You Q.D., Lin S.S., Li Z., Gu H.Y., Zhang H.W., Tan Z., and Wang X. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother. Pharmacol. 58 (2006) 434-443
16. Guo Q.L., Lin S.S., You Q.D., Gu H.Y., Yu J., Zhao L., Qi Q., Liang F., Tan Z., and Wang X. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci. 78 (2006) 1238-1245
17. Wang Q., Bai Z.L., Xuan L., Hou L., and Zhang B. Inhibitory role of transcription factor COUP-TFII in expression of hTERT in HeLa cells. Chin. Med. Sci. J. 19 (2004) 157-163
18. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., and Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21 (1999) 220-224
19. Jagadeesh S., Kyo S., and Banerjee P.P. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res. 66 (2006) 2107-2115
20. Kimura A., Ohmichi M., Kawagoe J., Kyo S., Mabuchi S., Takahashi T., Ohshima C., Arimoto-Ishida E., Nishio Y., Inoue M., Kurachi H., Tasaka K., and Murata Y. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23 (2004) 4505-4515
21. Xu X., Sakon M., Nagano H., Hiraoka N., Yamamoto H., Hayashi N., Dono K., Nakamori S., Umeshita K., Ito Y., Matsuura N., and Monden M. Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol. Rep. 11 (2004) 25-32
22. Roy H.K., Olusola B.F., Clemens D.L., Karolski W.J., Ratashak A., Lynch H.T., and Smyrk T.C. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis 23 (2002) 201-205
23. Yamamoto S., Tomita Y., Hoshida Y., Morooka T., Nagano H., Dono K., Umeshita K., Sakon M., Ishikawa O., Ohigashi H., Nakamori S., Monden M., and Aozasa K. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin. Cancer Res. 10 (2004) 2846-2850
24. Ang K.L., Shi D.L., Keong W.W., and Epstein R.J. Upregulated Akt signaling adjacent to gastric cancers: implications for screening and chemoprevention. Cancer Lett. 225 (2005) 53-59
25. Kang S.S., Kwon T., Kwon D.Y., and Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274 (1999) 13085-13090
26. Bu X., Jia F., Wang W., Guo X., Wu M., and Wei L. Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma Cells. BMC Cancer 7 (2007) 208
27. Maida Y., Kyo S., Kanaya T., Wang Z., Yatabe N., Tanaka M., Nakamura M., Ohmichi M., Gotoh N., Murakami S., and Inoue M. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 21 (2002) 4071-4079
28. Akiyama M., Hideshima T., Hayashi T., Tai Y.T., Mitsiades C.S., Mitsiades N., Chauhan D., Richardson P., Munshi N.C., and Anderson K.C. Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 63 (2003) 18-21
29. Kawauchi K., Ihjima K., and Yamada O. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3′-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. J. Immunol. 174 (2005) 5261-5269
30. Kim Y.W., Hur S.Y., Kim T.E., Lee J.M., Namkoong S.E., Ki I.K., and Kim J.W. Protein kinase C modulates telomerase activity in human cervical cancer cells. Exp. Mol. Med. 33 (2001) 156-163